Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice

por Smith, Mitchell R, Joshi, Indira, Jin, Fang, Obasaju, Coleman
Publicado 2005

Pemetrexed clinical studies in performance status 2 patients with non-small cell lung cancer (Review)

por ZINNER, RALPH, GRUL, CARLA VISSEREN, SPIGEL, DAVID R., OBASAJU, COLEMAN
Publicado 2015

Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing pro...

por Soulières, Denis, Aguilar, Jose Luis, Chen, Eric, Misiukiewicz, Krzysztof, Ernst, Scott, Lee, Hyun Jung, Bryant, Katherine, He, Shuang, Obasaju, Coleman K., Chang, Shao-Chun, Chin, Steve, Adkins, Douglas
Publicado 2016

Operational strategies in US cancer centers of excellence that support the successful accrual of racial and ethnic minorities in clinical trials

por Regnante, Jeanne M., Richie, Nicole, Fashoyin-Aje, Lola, Hall, Laura Lee, Highsmith, Quita, Louis, J'Aimee, Turner, Kenneth, Hoover, Spencer, Lee, Simon Craddock, González, Evelyn, Williams, Erin, Adams, Homer, Obasaju, Coleman, Sargeant, Ify, Spinner, Jovonni, Reddick, Christopher, Gandee, Marianne, Geday, Madeline, Dang, Julie, Watson, Rayneisha, Chen, Moon S.
Publicado 2020

PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed...

por Zinner, Ralph G., Obasaju, Coleman K., Spigel, David R., Weaver, Robert W., Beck, J. Thaddeus, Waterhouse, David M., Modiano, Manuel R., Hrinczenko, Borys, Nikolinakos, Petros G., Liu, Jingyi, Koustenis, Andrew G., Winfree, Katherine B., Melemed, Symantha A., Guba, Susan C., Ortuzar, Waldo I., Desaiah, Durisala, Treat, Joseph A., Govindan, Ramaswamy, Ross, Helen J.
Publicado 2015